Consensus guidelines for the definition, detection and interpretation of immunogenic cell death L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ... Journal for immunotherapy of cancer 8 (1), 2020 | 898 | 2020 |
Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 861 | 2014 |
Detection of immunogenic cell death and its relevance for cancer therapy J Fucikova, O Kepp, L Kasikova, G Petroni, T Yamazaki, P Liu, L Zhao, ... Cell death & disease 11 (11), 1013, 2020 | 694 | 2020 |
Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 585 | 2014 |
Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic … R Spisek, A Charalambous, A Mazumder, DH Vesole, S Jagannath, ... Blood, The Journal of the American Society of Hematology 109 (11), 4839-4845, 2007 | 467 | 2007 |
Combinatorial strategies for the induction of immunogenic cell death L Bezu, LC Gomes-da-Silva, H Dewitte, K Breckpot, J Fucikova, R Spisek, ... Frontiers in immunology 6, 187, 2015 | 452 | 2015 |
Human tumor cells killed by anthracyclines induce a tumor-specific immune response J Fucikova, P Kralikova, A Fialova, T Brtnicky, L Rob, J Bartunkova, ... Cancer research 71 (14), 4821-4833, 2011 | 436 | 2011 |
Molecular and translational classifications of DAMPs in immunogenic cell death AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, JM Bravo-San Pedro, ... Frontiers in immunology 6, 588, 2015 | 411 | 2015 |
Základy imunologie V Hořejší, J Bartůňková, T Brdička, R Špíšek Triton, 1998 | 383 | 1998 |
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy J Pol, E Vacchelli, F Aranda, F Castoldi, A Eggermont, I Cremer, ... Oncoimmunology 4 (4), e1008866, 2015 | 312 | 2015 |
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors S Yamazaki, AJ Bonito, R Spisek, M Dhodapkar, K Inaba, RM Steinman Blood, The Journal of the American Society of Hematology 110 (13), 4293-4302, 2007 | 273 | 2007 |
Calreticulin and cancer J Fucikova, R Spisek, G Kroemer, L Galluzzi Cell research 31 (1), 5-16, 2021 | 259 | 2021 |
Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma S Partlová, J Bouček, K Kloudová, E Lukešová, M Zábrodský, M Grega, ... Oncoimmunology 4 (1), e965570, 2015 | 245 | 2015 |
Trial Watch: Toll-like receptor agonists in cancer immunotherapy M Smith, E García-Martínez, MR Pitter, J Fucikova, R Spisek, L Zitvogel, ... Oncoimmunology 7 (12), e1526250, 2018 | 228 | 2018 |
Frequent and specific immunity to the embryonal stem cell–associated antigen SOX2 in patients with monoclonal gammopathy R Spisek, A Kukreja, LC Chen, P Matthews, A Mazumder, D Vesole, ... The Journal of experimental medicine 204 (4), 831-840, 2007 | 219 | 2007 |
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology I Vanmeerbeek, J Sprooten, D De Ruysscher, S Tejpar, P Vandenberghe, ... Oncoimmunology 9 (1), 1703449, 2020 | 210 | 2020 |
Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors D Rozkova, R Horvath, J Bartunkova, R Spisek Clinical immunology 120 (3), 260-271, 2006 | 208 | 2006 |
High hydrostatic pressure induces immunogenic cell death in human tumor cells J Fucikova, I Moserova, I Truxova, I Hermanova, I Vancurova, S Partlova, ... International journal of cancer 135 (5), 1165-1177, 2014 | 194 | 2014 |
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy I Adkins, J Fucikova, AD Garg, P Agostinis, R Špíšek Oncoimmunology 3 (12), e968434, 2014 | 193 | 2014 |
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients I Truxova, L Kasikova, M Hensler, P Skapa, J Laco, L Pecen, L Belicova, ... Journal for ImmunoTherapy of Cancer 6, 1-13, 2018 | 182 | 2018 |